These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35253471)
1. Review of Telemedicine for Management of Acne Patients. Gu L; Lipner SR J Cutan Med Surg; 2022; 26(4):393-397. PubMed ID: 35253471 [TBL] [Abstract][Full Text] [Related]
2. Comparison of teledermatological examinations with conventional office visits in management of acne vulgaris: A review of current literature. Bodle L; Hunger RE; Seyed Jafari SM J Cosmet Dermatol; 2022 Aug; 21(8):3292-3299. PubMed ID: 34859946 [TBL] [Abstract][Full Text] [Related]
3. Utilization of Asynchronous and Synchronous Teledermatology in a Large Health Care System During the COVID-19 Pandemic. Kazi R; Evankovich MR; Liu R; Liu A; Moorhead A; Ferris LK; Falo LD; English JC Telemed J E Health; 2021 Jul; 27(7):771-777. PubMed ID: 33074786 [No Abstract] [Full Text] [Related]
4. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. Falotico JM; Gu L; Lipner SR J Cosmet Dermatol; 2022 Oct; 21(10):4105-4106. PubMed ID: 35866349 [No Abstract] [Full Text] [Related]
5. Asynchronous Teledermatology Assessment of Young Adult Acne Likely Concordant With In-Person Evaluation. Jacoby T; Woolard A; Chamoun S; Moy R J Drugs Dermatol; 2021 Apr; 20(4):432-435. PubMed ID: 33852240 [TBL] [Abstract][Full Text] [Related]
6. Patient Perceptions and Satisfaction With Teledermatology During the COVID-19 Pandemic: A Survey-Based Study. Yeroushalmi S; Millan SH; Nelson K; Sparks A; Friedman AJ J Drugs Dermatol; 2021 Feb; 20(2):178-183. PubMed ID: 33538563 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Pediatric Dermatology Conditions Across Telehealth and In-Person Visits During the COVID-19 Pandemic. Duan G; Lambert R; Hight R; Rosenblatt A J Drugs Dermatol; 2022 Nov; 21(11):1260-1263. PubMed ID: 36342725 [TBL] [Abstract][Full Text] [Related]
8. Teledermatology during the COVID-19 pandemic: Experience at a tertiary care centre in North India. Handa S; Mehta H; Bishnoi A; Vinay K; Mahajan R; Narang T; Kumaran MS; De D; Dogra S; Parsad D Dermatol Ther; 2021 Jul; 34(4):e15022. PubMed ID: 34089561 [TBL] [Abstract][Full Text] [Related]
9. Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic. Gu L; Diaz SM; Lipner SR J Cosmet Dermatol; 2022 Jan; 21(1):36-38. PubMed ID: 34757675 [No Abstract] [Full Text] [Related]
10. Long-term results of teledermatology for acne patients during COVID-19 pandemic. Villani A; Annunziata MC; Megna M; Scalvenzi M; Fabbrocini G J Cosmet Dermatol; 2022 Apr; 21(4):1356-1357. PubMed ID: 35090188 [No Abstract] [Full Text] [Related]
11. Teledermatology in South Dakota: Uses and Patient Centered Improvement in a Rural Setting. DeVries BL; Brodersen KR; Mechels HN; DeVries JD; Knutson BD S D Med; 2022 Jun; 75(6):258-262. PubMed ID: 36206566 [TBL] [Abstract][Full Text] [Related]
13. When is synchronous telehealth acceptable for pediatric dermatology? Kohn LL; Pickett K; Day JA; Torres-Zegarra C; Plost G; Gurnee E; Prok L; Olson CA; Manson SM; Bruckner AL Pediatr Dermatol; 2022 Mar; 39(2):236-242. PubMed ID: 35178735 [TBL] [Abstract][Full Text] [Related]
14. Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study. Moreno-Ramírez D; Duarte-Ferreras MA; Ojeda-Vila T; García-Morales I; Conejo-Mir MD; Fernández-Orland A; Sánchez-Del-Campo AI; Eiris N; Carrizosa AM; Ruiz-de-Casas A; de-la-Torre JM; Herrerías-Esteban JM; Ferrándiz L J Am Acad Dermatol; 2022 Nov; 87(5):1186-1189. PubMed ID: 35271937 [No Abstract] [Full Text] [Related]
15. Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256". Potestio L; Villani A; Raia F; Fabbrocini G; Martora F J Cosmet Dermatol; 2023 Mar; 22(3):1134-1135. PubMed ID: 36700374 [No Abstract] [Full Text] [Related]
16. Teledermatology for acne patients: How to reduce face-to-face visits during COVID-19 pandemic. Villani A; Annunziata MC; Abategiovanni L; Fabbrocini G J Cosmet Dermatol; 2020 Aug; 19(8):1828. PubMed ID: 32490578 [No Abstract] [Full Text] [Related]
17. Direct-to-Consumer Teledermatology Growth: A Review and Outlook for the Future. Ranpariya V; Kats D; Lipoff JB Cutis; 2022 Apr; 109(4):211-217. PubMed ID: 35659836 [TBL] [Abstract][Full Text] [Related]
18. Moving forward with teledermatology: Operational challenges of a hybrid in-person and virtual practice. Yi JZ; Reynolds RV; Olbricht SM; McGee JS Clin Dermatol; 2021; 39(4):707-709. PubMed ID: 34809777 [TBL] [Abstract][Full Text] [Related]
19. Letter to the editor regarding article "Gu L, Diaz SM, Lipner SR. Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic. J Cosmet Dermatol. 2022;21(1):36-38.". Potestio L; Fabbrocini G; Villani A J Cosmet Dermatol; 2022 Nov; 21(11):6441-6442. PubMed ID: 35460317 [TBL] [Abstract][Full Text] [Related]
20. Increased utilization of teledermatology among Medicare Part B beneficiaries during the COVID-19 pandemic. Gronbeck C; Grant-Kels JM; Lu J; Feng H Clin Dermatol; 2022; 40(6):760-763. PubMed ID: 36075538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]